| Does indomethacin affect the control of breathing in premature infants? | |
| | |
MedLine Citation:
|
PMID: 2766924 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The effect of indomethacin on the control of breathing was simultaneously evaluated in 10 premature infants who had significant patent ductus arteriosus and received indomethacin therapy. In an attempt to maintain high plasma level in these infants of advanced postnatal age (greater than or equal to 6 weeks), indomethacin was administered intravenously at a dosage of 0.3 mg/kg, at 8-hour intervals, for a total of three doses. Following indomethacin therapy, there was a significant increase in tidal volume, minute ventilation, tidal volume/inspiratory time and in airway pressure (P0.1, Pmax) generated during airway occlusion. Seven infants required lower ventilatory rates after study. In spite of desirable plasma indomethacin level, there was no significant improvement in echo left atrium/aortic root dimension ratio, cardiovascular dysfunction score and in blood pH, PO2 and PCO2. None of the infants showed clinical evidence of ductus closure. The results of the study suggested that indomethacin may stimulate respiration and that endogenous prostaglandin may play a role in the regulation of breathing. |
| | |
Authors:
|
T F Yeh; A Wilks |
Related Documents
:
|
2863804 - Risk factors for retrolental fibroplasia: experience with 3,025 premature infants. nati... 2306584 - Asymmetrical pulmonary changes in premature infants with surgical closure of a persiste... 11176324 - Clinical correlations in infants in the neonatal intensive care unit with varying sever... 20545984 - Is combined atrial volumetrics by two-dimensional echocardiography a suitable measure f... 7416784 - Facial palsy in an infant with coarctation of the aorta and hypertension. 1919904 - Congenital heart disease, parental stress, and infant-mother relationships. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Developmental pharmacology and therapeutics Volume: 12 ISSN: 0379-8305 ISO Abbreviation: Dev Pharmacol Ther Publication Date: 1989 |
Date Detail:
|
Created Date: 1989-09-28 Completed Date: 1989-09-28 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 8003947 Medline TA: Dev Pharmacol Ther Country: SWITZERLAND |
Other Details:
|
Languages: eng Pagination: 211-6 Citation Subset: IM |
Affiliation:
|
Division of Neonatology, Cook County Children's Hospital, Chicago, Ill. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Ductus Arteriosus, Patent
/
drug therapy*,
physiopathology Humans Indomethacin / pharmacokinetics, pharmacology* Infant Infant, Newborn Infant, Premature / physiology* Respiration / drug effects* Respiratory Function Tests |
| Chemical | |
Reg. No./Substance:
|
53-86-1/Indomethacin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effect of formula feeding on oral absorption of caffeine in premature infants.
Next Document: Characterization of the hsp70 multigene family of Caenorhabditis elegans.